Merck (NYSE: MRK) announced the completion of its acquisition of Terns Pharmaceuticals (NASDAQ: TERN) for $53.00 per share in cash ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions